Many Americans are not taking GLP-1 drugs as prescribed due to cost and access barriers

A report indicates that millions of Americans are not using their GLP-1 medications the way they were prescribed. Cost and access barriers are the main reasons, pushing some patients to modify their dosing or schedule. Others are turning to unapproved versions of the drugs as a cheaper alternative. The findings highlight the gap between prescribed treatment and actual patient use. The source is Ars Technica.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in